24599-25-5 Usage
Description
ACRYLAMIDO BUFFER, also known as Acryloylglycine, is a vinyl monomer that contains both an amido and carboxylic group. It is widely utilized in various industries, including pharmaceutical, food, and cosmetic, as a synthetic intermediate. Additionally, it plays a crucial role in biology for preserving the integrity of microorganisms.
Uses
Used in Pharmaceutical Industry:
ACRYLAMIDO BUFFER is used as a synthetic intermediate for the development of various pharmaceutical products. Its unique chemical structure allows it to be a versatile building block in the synthesis of different drugs and medications.
Used in Food Industry:
ACRYLAMIDO BUFFER is used as an additive to enhance the quality and shelf life of various food products. Its ability to maintain the integrity of microorganisms makes it a valuable component in the preservation and safety of the food supply.
Used in Cosmetic Industry:
ACRYLAMIDO BUFFER is used as a key ingredient in the formulation of cosmetics, particularly those that require a stable and consistent product. Its properties contribute to the overall performance and effectiveness of the cosmetic products.
Used in Biology:
ACRYLAMIDO BUFFER is used as a preservative to maintain the integrity of microorganisms in biological research and applications. Its ability to protect and stabilize these organisms is essential for various scientific studies and experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 24599-25-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,5,9 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 24599-25:
(7*2)+(6*4)+(5*5)+(4*9)+(3*9)+(2*2)+(1*5)=135
135 % 10 = 5
So 24599-25-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO3/c1-2-4(7)6-3-5(8)9/h2H,1,3H2,(H,6,7)(H,8,9)
24599-25-5Relevant articles and documents
COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE
-
Paragraph 0897, (2021/10/02)
The invention provides compounds that are inhibitors of the protein embryonic ectoderm development (EED), pharmaceutical compositions, their use in modulating the activity of EED, and their use in the treatment of medical disorders, such as cancer. The invention further provides methods of treating medical disorders, such as cancer, and covalently modifying and/or modulating the activity of EED, using an agent that reacts with, and forms a covalent bond to, cysteine324 of EED.
Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
Berdan, Charles A.,Ho, Raymond,Lehtola, Haley S.,To, Milton,Hu, Xirui,Huffman, Tucker R.,Petri, Yana,Altobelli, Chad R.,Demeulenaere, Sasha G.,Olzmann, James A.,Maimone, Thomas J.,Nomura, Daniel K.
, p. 1027 - 22,1035 (2019/07/17)
-
FREE-STANDING NON-FOULING POLYMERS, THEIR COMPOSITIONS, AND RELATED MONOMERS
-
Page/Page column 42, (2017/01/23)
Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.
